On April 3, 2023 Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) ("Theratechnologies"), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported that it will report financial results for its first quarter 2023 ended February 28, on Wednesday, April 12, 2023 (Press release, Theratechnologies, APR 3, 2023, View Source [SID1234629761]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference call will be held on Wednesday, April 12, 2023, hosted by Mr. Paul Lévesque, President and Chief Executive Officer, and begin at 8:30 a.m. ET. Joining Mr. Lévesque on the call will be other members of the management team, including Chief Financial Officer Mr. Philippe Dubuc, Chief Medical Officer Dr. Christian Marsolais, and Global Commercial Officer Mr. John Leasure, who will be available to answer questions from participants following prepared remarks.

Participants are encouraged to join the call at least ten minutes in advance to secure access.

Conference call dial-in and replay information is below:

CONFERENCE CALL INFORMATION
Conference Call Date: April 12, 2023
Conference Call Time: 8:30 AM ET
North America Dial-in: 1-877-513-4119
International Dial-in: 1-412-902-6615
Access Code: 4314981
CONFERENCE CALL REPLAY
North America Dial-in: 1-877-344-7529
International Dial-in: 1-412-317-0088
Replay Access Code: 8857934
Replay End Date April 19, 2023
The live conference call will be accessible via webcast at:
View Source